Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Movement Disorders : Official Journal of the Movement Disorder Society|September 2, 2008
Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and ParkinsonismJohn G Nutt, Steven A Gunzler, Trish Kirchhoff, et al.
BMC Medical Research Methodology|January 20, 2019
How to design a dose-finding study using the continual reassessment methodGraham M Wheeler, Adrian P Mander, Alun Bedding, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 10, 2019
Normative data from linear and nonlinear quantile regression in CANTAB: Cognition in mid-to-late life in an epidemiological sampleRosemary A Abbott, Caroline Skirrow, Martha Jokisch, et al.
Journal of Biopharmaceutical Statistics|November 21, 2007
Innovative approaches for designing and analyzing adaptive dose-ranging trialsBjörn Bornkamp, Frank Bretz, Alex Dmitrienko, et al.
Expert Review of Neurotherapeutics|December 27, 2014
Charting a path toward combination therapy for Alzheimer's diseaseDiane Stephenson, Dan Perry, Cynthia Bens, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 21, 2007
Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic strokeGiora Z Feuerstein, Margaret M Zaleska, Michael Krams, et al.
Plos One|January 29, 2021
Accurate prediction of clinical stroke scales and improved biomarkers of motor impairment from robotic measurementsDimitris K Agrafiotis, Eric Yang, Gary S Littman, et al.
Stroke|December 17, 2013
Robotic measurement of arm movements after stroke establishes biomarkers of motor recoveryHermano I Krebs, Michael Krams, Dimitris K Agrafiotis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 17, 2014
Down syndrome and Alzheimer's disease: Common pathways, common goalsDean Hartley, Thomas Blumenthal, Maria Carrillo, et al.
Pageof 6